Stocks and Investing Stocks and Investing
Fri, June 28, 2024
Thu, June 27, 2024

Paul Matteis Maintained (ALNY) at Strong Buy with Increased Target to $295 on, Jun 27th, 2024


Published on 2024-10-28 12:08:54 - WOPRAI, Paul Matteis
  Print publication without navigation


Paul Matteis of Stifel, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Strong Buy with Increased Target from $215 to $295 on, Jun 27th, 2024.

Paul has made no other calls on ALNY in the last 4 months.



There are 11 other peers that have a rating on ALNY. Out of the 11 peers that are also analyzing ALNY, 2 agree with Paul's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Michael Ulz of "Morgan Stanley" Maintained at Hold with Increased Target to $250 on, Tuesday, June 25th, 2024
  • Tiago Fauth of "Wells Fargo" Maintained at Hold with Increased Target to $207 on, Tuesday, June 25th, 2024


These are the ratings of the 9 analyists that currently disagree with Paul


  • David Lebovitz of "Citigroup" Maintained at Strong Buy with Increased Target to $291 on, Tuesday, June 25th, 2024
  • Gena Wang of "Barclays" Maintained at Buy with Increased Target to $291 on, Tuesday, June 25th, 2024
  • Liisa Bayko of "Evercore ISI Group" Maintained at Buy with Increased Target to $260 on, Tuesday, June 25th, 2024
  • Ritu Baral of "TD Cowen" Maintained at Strong Buy with Increased Target to $282 on, Tuesday, June 25th, 2024
  • Patrick Trucchio of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $400 on, Monday, June 24th, 2024
  • Joseph Stringer of "Needham" Maintained at Strong Buy with Increased Target to $275 on, Monday, June 24th, 2024
  • Kostas Biliouris of "BMO Capital" Maintained at Buy and Held Target at $234 on, Monday, June 24th, 2024
  • Whitney Ijem of "Canaccord Genuity" Maintained at Strong Buy and Held Target at $283 on, Friday, June 21st, 2024
  • Keay Nakae of "Chardan Capital" Maintained at Strong Buy and Held Target at $225 on, Friday, May 3rd, 2024
Contributing Sources